Company Description
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally.
The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.
It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device.
Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders.
The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors.
Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
| Country | United States |
| Founded | 2004 |
| IPO Date | Jun 12, 2017 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 106 |
| CEO | Paul Gudonis |
Contact Details
Address: 137 Portland Street, 4th Floor Boston, Massachusetts 02114 United States | |
| Phone | 617 996 9058 |
| Website | myomo.com |
Stock Details
| Ticker Symbol | MYO |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001369290 |
| CUSIP Number | 62857J201 |
| ISIN Number | US62857J2015 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Paul R. Gudonis | Chairman, President and Chief Executive Officer |
| David A. Henry | Chief Financial Officer |
| Dr. Harry Kovelman M.D. | Chief Medical Officer |
| Colin Anderson | Global Director of Operations |
| Joseph Chicoskie | Director of Marketing |
| Galina Shtivelman | Senior Director of Human Resources |
| Micah J. Mitchell | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 6, 2024 | 10-Q | Quarterly Report |
| Nov 6, 2024 | 8-K | Current Report |
| Nov 4, 2024 | 144 | Filing |
| Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 3, 2024 | 144 | Filing |
| Sep 4, 2024 | 144 | Filing |
| Sep 3, 2024 | 144 | Filing |
| Aug 28, 2024 | EFFECT | Notice of Effectiveness |
| Aug 26, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Aug 13, 2024 | 8-K | Current Report |